Carcinogenic effects of skin transplantation and immunosuppression in mice

  • H. Reznik-Schüller
  • N. Kmoch
  • U. Mohr
Original Papers
  • 17 Downloads

Summary

C3H and B6D2 mice recieved skin transplants from an animal of the other strain. Three groups were immunosuppressed for varying periods of time, and with different doses of vinblastine, cyclophosphamide, or azathioprine. Following transplantation, control animals received daily injections of NaCl. All animals developed tumours of lymphoreticular origin, which would indicate that immunosuppression is only a secondary cause for tumour development, with antigenic stimulation being the primary factor.

Keywords

Public Health Cancer Research Cyclophosphamid Control Animal Tumour Development 

Carcinogene Wirkung von Hauttransplantation und Immunosuppression bei Mäusen

Zusammenfassung

C3H und B6D2 Mäuse erhielten Hautstücke von Tieren des jeweils anderen Mäusestammes transplantiert. Danach wurden drei Gruppen die Immunsuppressiva Vinblastin, Cyclophosphamid oder Azathioprin in unterschiedlicher Dosis und Behandlungsdauer und den Kontrolltieren nach Transplantation täglich NaCl verabreicht. Die Mäuse entwickelten Tumoren des lymphoreticulären Systems. Entsprechend unserer Befunde sehen wir in der antigenen Stimulierung eine wesentliche Hauptursache bei der Tumorinduktion nach Transplantation, während wir der Immunosuppression nur eine Sekundärwirkung zuschreiben.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Armstrong,M.Y.K., Gleichmann,E., Gleichmann,H., Beldotti,L., André-Schwarz,J., Schwartz,R.S.: Chronic allogeneic diseases. II. Development of lymphomas. J. exp. Med. 132, 417–439 (1970)Google Scholar
  2. Balner,H.: Immunosuppression and neoplasia. Rev. Europ. Études Clin. Et. Biol. 15, 599–604 (1970)Google Scholar
  3. Burnet,F.M.: The concept of immunological surveillance. Progr. exp. Tumor Res. (Basel) 13, 1–27 (1970)Google Scholar
  4. Gleichmann,H., Gleichmann,E.: Immunosuppression and neoplasia. I. A critical review of experimental carcinogenesis and the immunosurveillance theory. Klin. Wschr. 51, 255–259 (1973)Google Scholar
  5. Kay,S., Frable,W.J., Hume,D.M.: Cervical dysplasia and cancer developing in women on immunosuppression therapy for renal homotransplantation. Cancer (Philad.) 26, 1048–1052 (1970)Google Scholar
  6. Krueger,G.R.F., Malmgren,R.A., Berardi,C.W.: Malignant lymphomas and plasmocytosis in mice under prolonged immunosuppression and persistent antigenic stimulation. Transplantation 11, 138–144 (1971)Google Scholar
  7. McEvan,A., Petty,L.G.: Oncogenicity of immunosuppressive drugs. Letter to the editor. Lancet 1972 I, 326–327Google Scholar
  8. Metcalf,D.: Induction of reticular tumours in mice by repeated antigenic stimulation. Acta Un. int. Cancr. 19, 657–662 (1963)Google Scholar
  9. O'Conor,G.T.: Persistent immunologic stimulation as a factor in oncogenesis, with special reference for Burkitt's tumor. Amer. J. Med. 48, 279–285 (1970)Google Scholar
  10. Penn,I., Starzl,T.E.: Malignant tumors arising de nova in immunosuppressed organ transplant recipients. Transplantation 14, 407–417 (1972)Google Scholar
  11. Penn,I., Starzl,T.E.: Immunosuppression and cancer. Transplant Proc. 5, 943–947 (1973)Google Scholar
  12. Pritzger,K.P.H., Huang,S.N., Marshall,K.G.: Malignant tumours following immunosuppressive therapy. Canad. med. Ass. J. 103, 1362–1367 (1970)Google Scholar
  13. Schmähl,D.: Karzinogene Wirkung von Cyclophosphamid und Triazichon bei Ratten. Dtsch. Med. Wschr. 92, 1150–1152 (1967)Google Scholar
  14. Schmähl,D., Osswald,H.: Experimentelle Untersuchungen über carcinogene Wirkungen von Krebs-Chemotherapeutica und Immunosuppressiva. Arzneimittel-Forsch. (Drug Res.) 20, 1461–1467 (1970)Google Scholar
  15. Sheehan,R., Sklar,G., Tennenbaum,R.: Azathioprine effects on the development of hamster pouch carcinomas. Arch. Path. 91, 264–270 (1971)Google Scholar
  16. Suciu-Focu,N., Dumitrescu,V., Lazar,C., Nachtigal,M.: Host and tumor modifications associated with serial heterotransplantation of tumors through immunologically tolerant animals. Cancer Res. 30, 1681–1691 (1970)Google Scholar
  17. Tallent,M.B., Simmons,R.C., Najarian,J.S.: Primary carcinoma of the cervix appearing in immunosuppressed renal transplant recipient. Amer. J. Obstet. Gynec. 109, 663–664 (1971)Google Scholar

Copyright information

© Springer-Verlag 1976

Authors and Affiliations

  • H. Reznik-Schüller
    • 1
  • N. Kmoch
    • 1
  • U. Mohr
    • 1
  1. 1.Abteilung für Experimentelle PathologieMedizinische Hochschule HannoverHannover 61Germany

Personalised recommendations